Literature DB >> 10485071

First-pass renal perfusion imaging using MS-325, an albumin-targeted MRI contrast agent.

P V Prasad1, J Cannillo, D R Chavez, E S Pinchasin, R P Dolan, R Walovitch, R R Edelman.   

Abstract

RATIONALE AND
OBJECTIVES: MR angiography is proving to be a useful clinical study for the diagnosis of vascular disorders of renal arteries. However, its utility in terms of stenosis characterization is still limited. Renal perfusion could provide supplemental information that could allow for a comprehensive evaluation of renal artery stenosis by MR imaging.
METHODS: MS-325 is a small-molecule blood pool agent that reversibly binds with serum albumin and hence leads to higher relaxivity and longer residence times in the blood. In this study, the authors evaluated the use of MS-325 to perform first-pass perfusion imaging and contrast-enhanced MR angiography in the characterization of renal artery stenosis in an animal model.
RESULTS: Quantitative perfusion estimates were obtained in the renal cortex (258 +/- 19.8 mL/min/100 g) and are comparable to microsphere measurements (198 +/- 12.2 mL/min/100 g), given the practical constraints. Based on these measurements, perfusion showed minimal changes even when the diameter reductions reached 75%.
CONCLUSIONS: MS-325 could provide quantitative perfusion estimates that when combined with MR angiography may lead to comprehensive evaluation of renal artery stenosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485071     DOI: 10.1097/00004424-199909000-00003

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

1.  Pre-clinical results with Clariscan (NC100150 Injection); experience from different disease models.

Authors:  A Bjørnerud; L O Johansson; H K Ahlström
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

Review 2.  Functional MRI of the kidney: tools for translational studies of pathophysiology of renal disease.

Authors:  Pottumarthi V Prasad
Journal:  Am J Physiol Renal Physiol       Date:  2006-05

Review 3.  Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Authors:  Zhibo Liu; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

Review 4.  Assessment of renal function with dynamic contrast-enhanced MR imaging.

Authors:  Louisa Bokacheva; Henry Rusinek; Jeff L Zhang; Vivian S Lee
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

Review 5.  MRI of the kidney-state of the art.

Authors:  J J Nikken; G P Krestin
Journal:  Eur Radiol       Date:  2007-07-24       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.